Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Visualization of Malignant Glial Tumors
NCT01128218Phase 2Completed
- Sponsor
- Southern Illinois University
- Start
- Mar 2011
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in malignant glioma, sponsored by Southern Illinois University. Started Mar 2011; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01128218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128218.